Mesothelioma Drug Web Directory, and Resources

Mesothelioma Drug Resources

This site contains resources and articles for you to use when you are looking for information about mesothelioma drug. This site has articles, links to mesothelioma drug, information and news. In the future we will have reviews of products that will help you make your decision easier with mesothelioma drug, so you can save time

Featured Mesothelioma Drug Article

Mesothelioma Standard Treatment Options II

By: Govt

Standard treatment options:

1. Symptomatic treatment to include drainage of effusions, chest tube pleurodesis, or thoracoscopic pleurodesis.
2. Palliative surgical resection in selected patients.
3. Palliative radiation therapy.
4. Single-agent chemotherapy. Partial responses have been reported with doxorubicin, epirubicin, mitomycin, cyclophosphamide, cisplatin, carboplatin, and ifosfamide.
5. Combination chemotherapy (under clinical evaluation). Information about ongoing clinical trials is available from the NCI Cancer.gov Website.
6. Multimodality clinical trials.
7. Intracavitary therapy. Intrapleural or intraperitoneal administration of chemotherapeutic agents (e.g., cisplatin, mitomycin, and cytarabine) has been reported to produce transient reduction in the size of tumor masses and temporary control of effusions in small clinical studies. Additional studies are needed to define the role of intra-cavitary therapy.

The safety and efficacy of pemetrexed, an antifolate, and cisplatin in chemotherapy-n aive patients with malignant mesothelioma who were not eligible for curative surgery was demonstrated in a large phase III randomized trial. This trial compared pemetrexed (500 mg/m²) and cisplatin (75 mg/m² on day 1) with cisplatin alone (75 mg/m² on day 1 intravenously every 21 days). A total of 456 patients were enrolled: 226 patients received pemetrexed plus cisplatin and 222 patients received cisplatin alone; 8 patients did not receive therapy. After 117 patients had enrolled, folic acid and vitamin B₁₂ were added to reduce toxic effects. Folic acid (350-1,000 µg orally) was given daily, beginning 1 to 3 weeks before the first chemotherapy dose and continuing daily until 1 to 3 weeks after treatment ended. A vi tamin B₁₂ injection (1,000 µg intramuscularly ) was administered 1 to 3 weeks before the first chemotherapy dose and was repeated a....[MORE]

Sponsored Mesothelioma Drug Resources

These are our featured resources and providers for mesothelioma drug. Feel free to check them out if you are looking for resources and articles for you to use. This list includes sites with articles, mesothelioma drug resources, information and news.

Additional Mesothelioma Drug Resources

Warning: fsockopen() [function.fsockopen]: php_network_getaddresses: getaddrinfo failed: Name or service not known in /home/mesothel/public_html/ppc/ppc_parser.php(1) : eval()'d code on line 160

Warning: fsockopen() [function.fsockopen]: unable to connect to adrevenue.findwhat.com:80 (php_network_getaddresses: getaddrinfo failed: Name or service not known) in /home/mesothel/public_html/ppc/ppc_parser.php(1) : eval()'d code on line 160
RevenuePilot.com - Premiere Online Advertising Network
Attention Webmasters: Monetize your traffic. Get paid up to $2 for each unique click-through. No monthly limits, no conversion rates and no service charges. Receive your money by check or paypal anywhere in the world at no extra charge.

Admin report